Life Technologies | LIFE - Gross Profit On Sales



Life Technologies reported -15380000 in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Ardelyx USD 82.84M 15.02M Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Cipla INR 45.34B 66.3M Jun/2025
Clal Biotechnology ILS -857000 1.42M Jun/2022
Compugen USD -408000 1.2M Jun/2025
CSL USD 4.28B 939M Dec/2024
Galapagos EUR 61.25M 98.68M Mar/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Grifols EUR 766.49M 39.74M Dec/2024
Life Technologies -15380000 1.88M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
United Therapeutics USD 711M 9.1M Jun/2025